HomepageMedicineIDEAYA Names Stu Dorman as New Chief Commercial Officer Medicine IDEAYA Names Stu Dorman as New Chief Commercial Officer admin Posted on November 22, 2024 Dorman previously served as head of Gilead Sciences’ U.S. Oncology Unit. LEAVE A RESPONSE Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. admin View all posts Post navigation Previous PostLitter Robot 4 Review 2024: How It Measured Up in My Multi-Cat Home Next PostHow to Plan a Family Heritage Trip You Might Also Like Medicine FDA Approves Biocon Biologics’ Yesafili, an Eylea Biosimilar, for the Treatment of Multiple Ophthalmic Conditions admin May 22, 2024 Medicine FDA Approves Expanded Indication for Praluent to Lower LDL-C in Pediatric Patients with HeFH admin March 12, 2024 Medicine Is There a Correlation Between Medical Debt and Delayed Mental Health Care in the United States? admin July 20, 2024 Medicine FDA Approves Filsuvez for Epidermolysis Bullosa admin December 25, 2023
Medicine FDA Approves Biocon Biologics’ Yesafili, an Eylea Biosimilar, for the Treatment of Multiple Ophthalmic Conditions admin May 22, 2024
Medicine FDA Approves Expanded Indication for Praluent to Lower LDL-C in Pediatric Patients with HeFH admin March 12, 2024
Medicine Is There a Correlation Between Medical Debt and Delayed Mental Health Care in the United States? admin July 20, 2024